Literature DB >> 3373416

Pharmacokinetic model equations for the one- and two-compartment models with first-order processes in which the absorption and exponential elimination or distribution rate constants are equal.

H P Wijnand1.   

Abstract

In fitting the one-compartment open model with first-order processes to empirical data, it has frequently been found for single-dose administration that the absorption and elimination rate constants approach each other. If these rate constants tend to be equal, such combinations are impossible to solve with the general model equation. In 1968, Dost published a special model function by which the problems associated with the general model function can be circumvented. No solution, however, has been published for multiple-dose functions with the one-compartment model in which the absorption and elimination rate constants are equal. For a two-compartment open model with first-order processes, similar problems arise if the absorption and exponential distribution rate constants approach each other. Although this type of problems is often encountered in pharmacokinetic curve-fitting to empirical data, no exact solution has been published. Equations are given for multiple-dose administration with the one-compartment open model in which the absorption and elimination rate constants are equal, and for single-dose and multiple-dose administration with the two-compartment open model in which the absorption and exponential distribution rate constants are equal. Included are criteria to decide whether the new or the classical model functions should be applied in the case of a two-compartment open model.

Mesh:

Year:  1988        PMID: 3373416     DOI: 10.1007/bf01061864

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  4 in total

1.  Use of gamma distributed residence times in pharmacokinetics.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  Negative power functions of time in pharmacokinetics and their implications.

Authors:  M E Wise
Journal:  J Pharmacokinet Biopharm       Date:  1985-06

3.  A stable method for calculating oral drug absorption rate constants with two compartment disposition.

Authors:  L Saunders; T Natunen
Journal:  J Pharm Pharmacol       Date:  1973-12       Impact factor: 3.765

4.  A simple method for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first-order processes.

Authors:  M Bialer
Journal:  J Pharmacokinet Biopharm       Date:  1980-02
  4 in total
  10 in total

1.  Consequence of equal absorption, distribution and/or elimination rate constants.

Authors:  Y Plusquellec; F Courbon; S Nogarede
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Jul-Sep       Impact factor: 2.441

2.  Population analysis of weight-, age-, and sex-related differences in the pharmacokinetics of lopinavir in children from birth to 18 years.

Authors:  Vincent Jullien; Saïk Urien; Déborah Hirt; Constance Delaugerre; Elisabeth Rey; Jean-Paul Teglas; Paula Vaz; Christine Rouzioux; Marie-Laure Chaix; Eugenia Macassa; Ghislaine Firtion; Gérard Pons; Stéphane Blanche; Jean-Marc Tréluyer
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

3.  Multiple solutions, illegal parameter values, local minima of the sum of squares, and anomalous parameter estimates in least-squares fitting of the two-compartment pharmacokinetic model with absorption.

Authors:  R D Purves
Journal:  J Pharmacokinet Biopharm       Date:  1996-02

Review 4.  Current models in pharmacokinetics: applications in veterinary pharmacology.

Authors:  L D Kinabo; Q A McKellar
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

5.  Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy.

Authors:  Vincent Jullien; Jean-Marc Tréluyer; Elisabeth Rey; Patrick Jaffray; Anne Krivine; Laurence Moachon; Agnès Lillo-Le Louet; Anne Lescoat; Nicolas Dupin; Dominique Salmon; Gérard Pons; Saïk Urien
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Modeling of trough plasma bismuth concentrations.

Authors:  J E Bennett; J C Wakefield; L F Lacey
Journal:  J Pharmacokinet Biopharm       Date:  1997-02

7.  Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children?

Authors:  Naïm Bouazza; Déborah Hirt; Christophe Bardin; Serge Diagbouga; Boubacar Nacro; Hervé Hien; Emmanuelle Zoure; François Rouet; Adama Ouiminga; Stephane Blanche; Philippe Van De Perre; Jean-Marc Tréluyer; Philippe Msellati; Saik Urien
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

8.  The impact of lag time on the estimation of pharmacokinetic parameters. I. One-compartment open model.

Authors:  N G Nerella; L H Block; P K Noonan
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

9.  Population pharmacokinetics of emtricitabine in HIV-1-infected adult patients.

Authors:  Elodie Valade; Jean-Marc Tréluyer; Naïm Bouazza; Jade Ghosn; Frantz Foissac; Sihem Benaboud; Floris Fauchet; Jean-Paul Viard; Saïk Urien; Déborah Hirt
Journal:  Antimicrob Agents Chemother       Date:  2014-02-03       Impact factor: 5.191

10.  Population Pharmacodynamic Analyses of Human Anti-Rabies Virus Monoclonal Antibody (Ormutivimab) in Healthy Adult Subjects.

Authors:  Junnan Zhang; Nianmin Shi; Guohua Li; Li Li; Yunhua Bai; Liqing Yang; Weimin Zhao; Jian Gao; Jingshuang Wei; Wei Zhao; Lili Zhai; Peiyuan Huo; Lemin Ren; Lan Yu; Yufeng Li
Journal:  Vaccines (Basel)       Date:  2022-07-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.